Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders

Guillaume De Nanteuil, Philippe Gloanec, Suzette Beguin, Peter L. A. Giesen, H. Coenraad Hemker, Philippe Mennecier, Alain Rupin, Tony J. Verbeuren

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

    Original languageEnglish
    Pages (from-to)5047-5050
    Number of pages4
    JournalJournal of Medicinal Chemistry
    Volume49
    Issue number17
    DOIs
    Publication statusPublished - 25 Jul 2006

    Cite this

    De Nanteuil, G., Gloanec, P., Beguin, S., Giesen, P. L. A., Hemker, H. C., Mennecier, P., Rupin, A., & Verbeuren, T. J. (2006). Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders. Journal of Medicinal Chemistry, 49(17), 5047-5050. https://doi.org/10.1021/jm0606950